US News: Scientists Discover New Cure for the Deadliest Strain of Tuberculosis - PressFrom - United Kingdom
  •   
  •   

US NewsScientists Discover New Cure for the Deadliest Strain of Tuberculosis

06:40  15 august  2019
06:40  15 august  2019 Source:   msn.com

Remains of 19th-century American ‘vampire’ are analysed by scientists

Remains of 19th-century American ‘vampire’ are analysed by scientists Scientists haven’t actually found the resting place of Dracula - but they’ve done the next best thing, analysing the remains of a ‘vampire’ from the 19th century. 

Scientists were able to recreate the genome of the bacteria from remains of 1,000-year-old skeletons in southern Peru. Other researchers have argued there is other evidence that suggests the tuberculosis bacteria is older than 6,000 years.[1] This TB strain found in Peru is different from that

Tuberculosis ( TB ) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Dr. Pauline Howell tended to a patient suffering from a particularly virulent strain of tuberculosis at Sizwe Tropical Diseases Hospital in Johannesburg.

TSAKANE, South Africa — When she joined a trial of new tuberculosis drugs, the dying young woman weighed just 57 pounds.

Stricken with a deadly strain of the disease, she was mortally terrified. Local nurses told her the Johannesburg hospital to which she must be transferred was very far away — and infested with vervet monkeys.

“I cried the whole way in the ambulance,” Tsholofelo Msimango recalled recently. “They said I would live with monkeys and the sisters there were not nice and the food was bad and there was no way I would come back. They told my parents to fix the insurance because I would die.”

Scientists Reverse Aging in Rat Stem Cells

Scientists Reverse Aging in Rat Stem Cells A co-author of the study says the research could one day be used to help rejuvenate other tissues. It is possible that our findings could help with multiple brain conditions, including Alzheimer's, but as of now the most obvious is multiple sclerosis (MS), which is driven in large part by loss of function in the stem cells we studied." OPCs help to keep the brain healthy and are used by the body to make the myelin sheath, which protects our central nervous system. This myelin is attacked by the immune system in those with MS. White rat in hands on a blue background.

Two new drug therapies may be able to cure all forms of tuberculosis – even the ones most difficult to treat. “We will have something to offer every single patient,” says It presently takes six months of drug treatment to cure ordinary TB , and two years to cure people whose infections are resistant to drugs.

Scientists have found a key protein that can protect people from the highly contagious and life-threatening lung disease tuberculosis , leading medicine closer to finding new treatment strategies, which may be in the form of a vitamin D supplement.

Video: Tuberculosis 101 (Agence France-Press)

Five years later, Ms. Msimango, 25, is now tuberculosis-free. She is healthy at 103 pounds, and has a young son.

The trial she joined was small — it enrolled only 109 patients — but experts are calling the preliminary results groundbreaking. The drug regimen tested on Ms. Msimango has shown a 90 percent success rate against a deadly plague, extensively drug-resistant tuberculosis.

Sign Up For the Morning Briefing Newsletter

On Wednesday, the Food and Drug Administration effectively endorsed the approach, approving the newest of the three drugs used in the regimen. Usually, the World Health Organization adopts approvals made by the F.D.A. or its European counterpart, meaning the treatment could soon come into use worldwide.

Irish weather forecast: Wet and windy start to weekend with 'very strong' winds and showers on the way

Irish weather forecast: Wet and windy start to weekend with 'very strong' winds and showers on the way The west and northwest will be lashed by strong gusts tomorrow

The deadliest strain of tuberculosis is XDR- TB , the “extensively drug-resistant” type, meaning that many XDR- TB is rare but very lethal. Curing it takes up to two years, and the drugs Now a study, published in The New England Journal of Medicine by South African and American scientists , has

Scientists using a revolutionary approach have devised an antibiotic that may offset the mounting Called teixobactin, it hails from a new tool to screen for soil bacteria that exude natural antibiotic In lab dish experiments, teixobactin killed resistant strains of tuberculosis and Staphylococcus -- a

Gallery: 10 biggest health threats in 2019 as revealed by WHO (Photo Services)

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis
Scientists Discover New Cure for the Deadliest Strain of Tuberculosis

Tuberculosis has now surpassed AIDS as the world’s leading infectious cause of death, and the so-called XDR strain is the ultimate in lethality. It is resistant to all four families of antibiotics typically used to fight the disease.

Pig hearts could be transplanted into humans within three years – report

Pig hearts could be transplanted into humans within three years – report The news comes on the 40th anniversary of the first successful heart transplant.

But a new study shows that's not true for mycobacteria, which cause tuberculosis ( TB ) in humans—and that may explain why the disease is Scientists have assumed that mycobacteria are so hard to kill because dormant cells exist even in patients with active disease and these cells are far

Some believe that the deadly strain of influenza originated somewhere from China. Smallpox virus is one of the world’s deadliest viruses that had killed more humans than any other virus in human history. There is no particular cure , but scientists are trying hard to find a cure . Soon there will be

Only a tiny fraction of the 10 million people infected by TB each year get this type, but very few of them survive it.

There are about 30,000 cases in over 100 countries. Three-quarters of those patients die before they even receive a diagnosis, experts believe, and among those who get typical treatment, the cure rate is only 34 percent.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Dr. Pauline Howell, right, runs trials of TB treatments at Sizwe.

The treatment itself is extraordinarily difficult. A typical regimen in South Africa requires up to 40 daily pills, taken for up to two years.

Other countries rely on even older regimens that include daily injections of antibiotics that can have devastating side effects, including deafness, kidney failure and psychosis.

But in the trial Ms. Msimango joined, nicknamed Nix-TB, patients took only five pills a day for six months.

The pills contain just three drugs: pretomanid, bedaquiline and linezolid. (Someday, the whole regimen might come in just one pill, as H.I.V. drugs do, one expert said.)

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times The Nix medication, left, compared with the typical XDR regimen, right, which requires up to 40 pills a day for two years.

Until recently, some advocacy groups opposed pretomanid’s approval, saying the drug needed further testing. But other TB experts argued that the situation is so desperate that risks had to be taken.

Dr. Gerald Friedland, one of the discoverers of XDR-TB and now an emeritus professor at Yale’s medical school, called Nix “a wonderful trial” that could revolutionize treatment: “If this works as well as it seems to, we need to do this now.”

A killer appears

News that tuberculosis had evolved a terrifying new strain first broke in 2006, when doctors at a global AIDS conference learned of a doomed group of tuberculosis patients in Tugela Ferry, a rural South African town.

Scientists reveal discovery of new species of stegosaur

Scientists reveal discovery of new species of stegosaur Stegosaurs are armoured dinosaurs recognisable by spike-like bones protruding from their spine and tails. Video: New dinosaur species was 'hiding' for decades (GeoBeats) require(["binding"], function (binding) { binding("wcVideoPlayer", "#video_player_436284cc-4d15-4bce-9a4c-3fe20b0e24ac").all(); }); Despite the specimen including only a few vertebrae and an upper arm bone, scientists concluded it was a new species and genus which dates to the middle Jurassic period – much earlier than most known stegosaurs.

TB is one of the world's deadliest diseases, killing more people than any other disease caused by a single infectious organism. June 4, 2015 — Scientists have discovered a new target for the fight against multi-resistant Mycobacterium tuberculosis is the main cause of tuberculosis .

Of the 53 patients in whom the strain had been detected, 52 were dead — most within a month of diagnosis. They were relatively young: The median age was 35.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Tsholofelo Msimango in her home in Tsakane. She was part of a small trial called Nix-TB, and today she’s free of TB.

Many of them had never been treated for TB before, meaning they had caught the drug-resistant strain from others who had been infected and had not developed it by failing to take their drugs. Several were health workers who were assumed to have caught it from patients.

Within months, South Africa realized it had cases of the deadly infection in 40 hospitals. Alarmed, W.H.O. officials called for worldwide testing.

The results showed that 28 countries, including the United States, had the deadly strain, XDR-TB, and that two-thirds of the cases were in China, India and Russia. It took far longer to determine how widespread it was in Africa, because most countries there could not do the sophisticated testing.

H.I.V., the virus that causes AIDS, helped drive the epidemic. Anyone infected with it is 25 times as likely to get TB, according to the W.H.O. But many victims, including Ms. Msimango, catch this type of TB without ever having H.I.V.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Tubes of TB cultures at the center.

In the early years, XDR-TB was a death sentence. Doctors tried every drug they could think of, from those used to treat leprosy to those for urinary tract infections.

“From 2007 to 2014, we threw the kitchen sink at it,’’ said Dr. Francesca Conradie, a researcher at the University of the Witwatersrand, Johannesburg, and director of the Nix trial.

The death rate was about 80 percent. Sometimes the drugs killed patients. In other cases, patients died of the disease, because they could not tolerate the drugs and stopped taking them.

Tuberculosis germs burrow deep into the lungs and barricade themselves inside clumps of dead cells. Breaking those nodules apart and killing all the bacteria inside requires taking drugs for months.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times A patient in the Nix trial receiving his medication at Sizwe. Many TB experts wanted the last of the drugs in the regimen approved quickly despite the trial’s small size.

Nearly all antibiotics cause nausea and diarrhea. But some, especially the injections, are far tougher on patients.

“Some get hallucinations,” said Dr. Pauline Howell, a tuberculosis researcher who runs the Nix trial at Sizwe Tropical Diseases Hospital in Johannesburg, where Ms. Msimango was treated. “I had one patient who tried to cut open his skin because he thought bugs were crawling under it.”

The drugs may leave patients in wheelchairs with vertigo, or deaf in just a weekend. Nerves in their feet and hands may wither until they can no longer walk or cook. One of Dr. Howell’s patients suffered so much from ringing in the ears that he tried to commit suicide.

Ms. Msimango, too, veered close to death because the drugs were too much for her.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Innocent Makamu was infected with XDR-TB, but got a spot in the Nix trial.

When she was 19, she said, she caught drug-resistant TB from another young woman — the temporarily homeless daughter of a friend of her mother.

Her mother had generously taken in the young woman and had told her daughter to share her bed, a common arrangement in townships like Tsakane. “A few weeks after she left, I started coughing,” Ms. Msimango said.

“She had not told us that she had drug-resistant TB and had defaulted,” she added, using a common term for dropping out of treatment.

At first, Ms. Msimango got her injections at a hospital and took her pills under her mother’s watchful eye. But they made her feel so awful that she secretly spat them out, stuffing them between the sofa cushions when her mother wasn’t looking.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Pool and table tennis are among the activities provided to TB patients at Sizwe. Treatment can require years in confinement.

After she defaulted twice herself, she was transferred to Sizwe, terrified that she would die alone.

No masks, no doctors

Although it lies in South Africa’s largest city, Sizwe does host monkeys, along with feral peacocks and the occasional mongoose. It has long been on the front lines of South Africa’s protracted battle against tuberculosis.

The hospital sits on an isolated hilltop 10 miles from downtown. The British built it in 1895 as Rietfontein Hospital to house victims of contagious diseases like leprosy, smallpox and syphilis.

Gandhi volunteered there during a 1904 bubonic plague outbreak, and Archbishop Desmond Tutu was a tuberculosis patient there in his youth.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times A mural on the wall at Sizwe, where patients participate in group therapy sessions. Months of isolation for treatment can be hard on patients.

In 1996, with the AIDS epidemic raging, the W.H.O. announced that South Africa had the world’s worst tuberculosis epidemic: 350 cases per 100,000 citizens.

That finding shocked the government, which had been using outdated approaches against the disease. Diagnoses were made by X-ray, which are less accurate than sputum tests, and doctors hospitalized every patient.

I visited shortly after the 1996 announcement, and the situation inside Rietfontein was unnerving. In the men’s ward, dozens of TB patients lay on cots only two feet apart; those with drug-resistant strains slept next to patients with the usual type.

No one wore a mask, and no doctor was on duty. At night, the patients shut them and turned up the heat, and the room became a deadly incubator.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times A technician handles colonies of tuberculosis strains for specialized testing at the Center for Tuberculosis in Johannesburg.

A return visit this month showed that far more than the name had changed (Sizwe means “nation” in Zulu).

The former men’s ward is now a mostly empty meeting hall. Patients with TB that is not drug-resistant are treated at home, and even those with partially drug-resistant strains are usually hospitalized only briefly.

The XDR-TB patients rest in a ward atop the hill, and golf carts transport those too weak to walk. Each patient has a separate room and bathroom, hookups for oxygen and lung suction, a TV and big windows and a door to the lawn outside.

The building has a sophisticated ventilation system, but it often breaks down, so the policy is to keep all the doors and windows open as much as possible, said Dr. Rianna Louw, the hospital’s chief executive.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Hospital workers at Sizwe. The hospital was originally built by the British to house patients with contagious diseases.

Patients can work in the garden, play pool or foosball, and take classes in sewing, beading or other crafts that might help them earn a living when they get out.

But the months of isolation needed for treatment can be tough. “Our children are scattered, they are falling apart!” a patient who gave her name only as Samantha shouted at a group-therapy session that turned into an airing of grievances.

“The father of my kids is in prison,” she said. “My firstborn son is arrested for robbing people in the street. That would not happen if I was home!”

The counselor interrupted to say: “We understand your frustration. But if we discharge you, we are taking a risk. You are not healthy. You can still expose people to your disease. That’s why you will stay a minimum of four months.”

A rush to approval?

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis © Joao Silva/The New York Times Ms. Msimango, right, with relatives at home. Before the trial, her medications made her feel so bad she secretly spat them out and hid the unused pills from her mother.

The regimen successfully tested at Sizwe is called BPaL, shorthand for the three drugs it comprises: bedaquiline, pretomanid and linezolid.

The BPaL regimen is “bold, because it’s three killer drugs instead of two killers plus some supportive ones,” Dr. Howell said.

Most regimens, she explained, rely on two harsh drugs that can destroy bacterial walls and include others that have fewer side effects but only stop TB bacteria from multiplying.

But even the new treatment poses hazards.

Short-term use of linezolid against severe hospital infections causes few problems, but use for many weeks against TB can kill nerves in the feet, making it hard to walk, or can suppress the bone marrow where blood cells are made. (To find the ideal linezolid dose, the Nix investigators have started a new trial, ZeNix.)

The F.D.A. approved bedaquiline in 2012 for use against multi-drug resistant TB (the XDR strain is an even deadlier subset), and in 2015 the W.H.O. followed suit. Until Wednesday, pretomanid was in dispute, although in June an F.D.A. advisory committee voted 14 to 4 to approve it.

Some advocacy groups argued at the time that the drug had been too little tested.

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis Secondary tuberculosis in lungs and close-up view of Mycobacterium tuberculosis bacteria, 3D illustration

“Pretomanid looks like a promising drug, but it’s being rushed forward, and we don’t want to see the F.D.A. lower the bar for approval,” Lindsay McKenna, co-director of the tuberculosis project at the Treatment Action Group, an advocacy organization, said in July.

Her organization and others had asked the F.D.A. to first demand more rigorous testing of the drug.

Pretomanid is not owned by a drug company but by the TB Alliance, a nonprofit based in New York that is seeking new treatments.

Dr. Mel Spigelman, the alliance’s president, had argued that a full clinical trial would be both impractical and unethical.

“Put yourself in a patient’s position,” he said. “Offered a choice between three drugs with a 90 percent cure rate, and 20 or more with less chance of cure — who would consent to randomization?”

Such a trial would cost $30 million and take five more years, he added: “That’s a very poor use of scarce resources.”

‘There is no survival here’

Scientists Discover New Cure for the Deadliest Strain of Tuberculosis Lonely sick Afro-American boy in face mask on blurred background, quarantine

Innocent Makamu, 32, was facing two years in the hospital when he chose to join the Nix trial in 2017.

Like Ms. Msimango, he also had caught drug-resistant TB from a roommate. A plumber, he had shared a room at a distant construction site with a carpenter.

“He was too much on the bottle,” Mr. Makamu said. “He kept defaulting.”

Soon afterward, he began feeling tired and lost his appetite. Doctors at the hospital near his home diagnosed tuberculosis, and put him on 29 daily pills and a daily injection.

“It was deep in my bum,” he said. “I couldn’t sit properly. It hurt every day.”

At the hospital, he watched two other inpatients wither and die because they could not stick to the regimen. “I thought, ‘Oh, there is no survival here.’”

Then further tests showed that he had full-blown XDR-TB. He was transferred to Sizwe and offered a spot in the Nix trial.

Some patients there who were on the standard 40-pill regimens discouraged him. “They said, ‘They are using you as guinea pigs,’” he said. “Even the nurses thought that.”

But he found the possibility of taking only five pills for six months very tempting, and so he volunteered. Within a month, he could tell it was working.

“Then the patients who called us ‘guinea pigs’ — they wished they had taken the research pills,” he said.

Explore the issues faced by the UK’s most vulnerable children and young people this summer and discover what you can do to help.

Scientists reveal discovery of new species of stegosaur.
Stegosaurs are armoured dinosaurs recognisable by spike-like bones protruding from their spine and tails. Video: New dinosaur species was 'hiding' for decades (GeoBeats) require(["binding"], function (binding) { binding("wcVideoPlayer", "#video_player_436284cc-4d15-4bce-9a4c-3fe20b0e24ac").all(); }); Despite the specimen including only a few vertebrae and an upper arm bone, scientists concluded it was a new species and genus which dates to the middle Jurassic period – much earlier than most known stegosaurs.

—   Share news in the SOC. Networks

Topical videos:

usr: 28
This is interesting!